Free Trial

OptimizeRx (OPRX) SEC Filings & 10K Form

OptimizeRx logo
$12.53 -0.33 (-2.57%)
Closing price 04:00 PM Eastern
Extended Trading
$12.52 -0.01 (-0.08%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent OptimizeRx SEC Filings

DateFilerForm TypeView
07/16/2025
10:35 AM
OptimizeRx (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SCHEDULE 13G/A
06/24/2025
6:45 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2025
3:31 PM
OptimizeRx (Issuer)
WASSON GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:33 PM
OptimizeRx (Issuer)
Vos Ellen O'Connor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:34 PM
OptimizeRx (Issuer)
Spangler Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:35 PM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:36 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
7:30 AM
OptimizeRx (Filer)
Form DEF 14A
04/30/2025
7:32 AM
OptimizeRx (Filer)
Form ARS
04/21/2025
1:47 PM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form SCHEDULE 13D/A
04/07/2025
11:15 PM
OptimizeRx (Filer)
Form EFFECT
03/28/2025
3:30 PM
OptimizeRx (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:46 PM
OptimizeRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
6:40 PM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:45 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
6:45 AM
OptimizeRx (Filer)
Form DEFA14A
03/10/2025
7:58 PM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form DFAN14A
03/10/2025
4:29 PM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form SCHEDULE 13D/A
03/10/2025
6:45 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
8:16 AM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:18 AM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:38 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:39 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:39 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:40 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
12:40 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
2:58 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
9:34 AM
OptimizeRx (Subject)
Samjo Management, LLC (Filed by)
Form SCHEDULE 13G/A
02/05/2025
10:41 AM
OptimizeRx (Subject)
Whetstone Capital Advisors, LLC (Filed by)
Form SCHEDULE 13D
02/04/2025
5:50 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
11:58 AM
OptimizeRx (Subject)
ROYCE & ASSOCIATES LP (Filed by)
Form SCHEDULE 13G
01/08/2025
3:37 PM
First Light Asset Management, LLC (Filed by)
OptimizeRx (Subject)
Form SCHEDULE 13G/A
12/27/2024
4:00 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:38 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
12/27/2024
2:18 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:08 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:08 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:09 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
7:50 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:46 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:47 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Limited-Time: 3 Small-Caps Tied to Today’s Biggest Trends (Ad)

AI breakthroughs. Inflation shocks. Energy rotations. The market is moving fast — and the biggest winners often start small. At Street Ideas, we focus on small-cap companies showing early momentum — before the crowd piles in.

“3 Under-the-Radar Stocks Triggering Early Signals”
12/20/2024
6:47 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:48 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
1:28 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:18 PM
AWM Investment Company, Inc. (Filed by)
OptimizeRx (Subject)
Form SC 13G
11/14/2024
10:25 AM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G/A
11/13/2024
9:25 AM
OptimizeRx (Subject)
Samjo Management, LLC (Filed by)
Form SC 13G
11/12/2024
8:37 AM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
7:30 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:53 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:30 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:26 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:25 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
4:22 PM
McCarthy Brian Clark (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OPRX) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners